Literature DB >> 2822186

Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction.

B R Zeeberg, H N Wagner.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2822186     DOI： 10.1007/BF02458864

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN： 0092-8240            Impact factor:   1.758


× No keyword cloud information.
  18 in total

1.  Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.

Authors:  J Logan; A P Wolf; C Y Shiue; J S Fowler
Journal:  J Neurochem       Date:  1987-01       Impact factor: 5.372

2.  Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.

Authors:  C D Arnett; C Y Shiue; A P Wolf; J S Fowler; J Logan; M Watanabe
Journal:  J Neurochem       Date:  1985-03       Impact factor: 5.372

3.  Strategies for in vivo measurement of receptor binding using positron emission tomography.

Authors:  J S Perlmutter; K B Larson; M E Raichle; J Markham; M A Mintun; M R Kilbourn; M J Welch
Journal:  J Cereb Blood Flow Metab       Date:  1986-04       Impact factor: 6.200

4.  Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.

Authors:  D F Wong; A Gjedde; H N Wagner; R F Dannals; K H Douglass; J M Links; M J Kuhar
Journal:  J Cereb Blood Flow Metab       Date:  1986-04       Impact factor: 6.200

5.  Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.

Authors:  K A Frey; R D Hichwa; R L Ehrenkaufer; B W Agranoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Characterization and subcellular localization of brain muscarinic receptors labelled in vivo by [3H]dexetimide.

Authors:  P M Laduron; P F Janssen
Journal:  J Neurochem       Date:  1979-12       Impact factor: 5.372

7.  Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain.

Authors:  D F Wong; H N Wagner; R F Dannals; J M Links; J J Frost; H T Ravert; A A Wilson; A E Rosenbaum; A Gjedde; K H Douglass
Journal:  Science       Date:  1984-12-21       Impact factor: 47.728

8.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography.

Authors:  M A Mintun; M E Raichle; M R Kilbourn; G F Wooten; M J Welch
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

9.  Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography.

Authors:  Y Samson; P Hantraye; J C Baron; F Soussaline; D Comar; M Mazière
Journal:  Eur J Pharmacol       Date:  1985-04-02       Impact factor: 4.432

10.  The characteristics of I-125 4-IQNB and H-3 QNB in vivo and in vitro.

Authors:  R E Gibson; D J Weckstein; E M Jagoda; W J Rzeszotarski; R C Reba; W C Eckelman
Journal:  J Nucl Med       Date:  1984-02       Impact factor: 10.057
View more
  4 in total

1.  Optimal tumor targeting by antibodies: development of a mathematical model.

Authors:  M J Chappell; G D Thomas; K R Godfrey; A R Bradwell
Journal:  J Pharmacokinet Biopharm       Date:  1991-04

Review 2.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

3.  Theoretical effects of radioligand diffusional gradients and microscopic neuroreceptor distribution in in vivo kinetic studies.

Authors:  B R Zeeberg; R C Reid; K A Murphy; R C Reba
Journal:  Bull Math Biol       Date:  1988       Impact factor: 1.758

4.  Exploring a mathematical model for the kinetics of beta-amyloid molecular imaging probes through a critical analysis of plaque pathology.

Authors:  Kooresh Shoghi-Jadid; Jorge R Barrio; Vladimir Kepe; Sung-Cheng Huang
Journal:  Mol Imaging Biol       Date:  2006 May-Jun       Impact factor: 3.488
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.